At AMP 2025, researchers unveiled advances in blood cancer diagnostics and placed AI‑driven pathology front and center. Presentations showcased highly sensitive ctDNA NGS panels for AML/other hematologic malignancies and discussions emphasized standardization, liquid‑biopsy integration and AI‑assisted variant interpretation to accelerate diagnosis and treatment selection. Organizers and speakers signaled that digital pathology and machine learning will move from research to routine practice, stressing validation, regulatory alignment and lab workflows. Conference previews underscored how integrated diagnostics—combining NGS, ctDNA and AI—are positioning labs to deliver faster, more actionable hematologic profiles.